Non-Invasive Chromosomal Evaluation of Trisomy Study
Completed
Conditions studied: Aneuploidy, Trisomy 21, Trisomy 18, Trisomy 13, Down Syndrome
In brief
This study is being conducted to provide clinically annotated samples to support continued improvements in the Ariosa Test content, methodology, specimen processing and quality control.
Key facts
- Study ID
- NCT02201862
- Run by
- Cindy Cisneros
- People needed
- 2000
- Starts
- 2014-04-01
- Expected to finish
- 2019-08-01
- Last updated by the study team
- 2020-04-30
Who can join
Age: 18 and older, up to 60. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- 1. Subject is at least 18 years old and can provide informed consent;
- 2. Subject has a viable singleton or twin pregnancy;
- 3. Subject is confirmed to be at least 10 weeks, 0 days gestation at the time of the study blood draw;
- 4. Subject is planning to undergo CVS and/or amniocentesis for the purpose of genetic analysis of the fetus OR the subject has already undergone CVS and/or amniocentesis and is known to have a fetus with a chromosomal abnormality confirmed by genetic analysis.
You may not qualify if…
- 1. Subject has known aneuploidy;
- 2. Subject is pregnant with more than two fetuses or has had sonographic evidence of three or more gestational sacs at any time during pregnancy;
- 3. Subject has a fetal demise (including natural or elective reduction) identified prior to consent;
- 4. Subject has history of malignancy treated with chemotherapy and/or major surgery, or bone marrow transplant;
Where it is running
- University California San Diego — San Diego, California, United States
- Women's Healthcare Group of PA — Oaks, Pennsylvania, United States
- Regional Obestrical Consultants — Chattanooga, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.